Group One Trading’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-294,500
| Closed | -$25M | – | 7325 |
|
|
2020
Q3 | $25M | Buy |
294,500
+147,600
| +100% | +$7.46M | 0.08% | 209 |
|
|
2020
Q2 | $5.21M | Buy |
146,900
+84,500
| +135% | +$2.47M | 0.02% | 782 |
|
|
2020
Q1 | $841K | Sell |
62,400
-83,000
| -57% | -$1.4M | 0.01% | 1652 |
|
|
2019
Q4 | $3.08M | Buy |
145,400
+20,900
| +17% | +$369K | 0.02% | 966 |
|
|
2019
Q3 | $1.65M | Buy |
124,500
+105,800
| +566% | +$1.56M | 0.01% | 1359 |
|
|
2019
Q2 | $259K | Sell |
18,700
-26,500
| -59% | -$399K | ﹤0.01% | 2661 |
|
|
2019
Q1 | $868K | Sell |
45,200
-1,283,800
| -97% | -$20.7M | 0.01% | 1511 |
|
|
2018
Q4 | $19M | Sell |
1,329,000
-715,900
| -35% | -$14.2M | 0.16% | 114 |
|
|
2018
Q3 | $42.6M | Sell |
2,044,900
-90,000
| -4% | -$2.13M | 0.34% | 35 |
|
|
2018
Q2 | $50.5M | Buy |
2,134,900
+632,600
| +42% | +$12.7M | 0.43% | 20 |
|
|
2018
Q1 | $21.9M | Buy |
1,502,300
+530,400
| +55% | +$8.67M | 0.22% | 77 |
|
|
2017
Q4 | $15.7M | Buy |
971,900
+544,600
| +127% | +$6.43M | 0.11% | 198 |
|
|
2017
Q3 | $5.97M | Buy |
427,300
+22,000
| +5% | +$219K | 0.05% | 437 |
|
|
2017
Q2 | $3.58M | Sell |
405,300
-296,500
| -42% | -$2.08M | 0.04% | 628 |
|
|
2017
Q1 | $4.54M | Buy |
701,800
+269,600
| +62% | +$1.37M | 0.05% | 443 |
|
|
2016
Q4 | $1.59M | Buy |
432,200
+5,700
| +1% | +$16.9K | 0.02% | 1044 |
|
|
2016
Q3 | $1.39M | Sell |
426,500
-162,100
| -28% | -$453K | 0.02% | 1058 |
|
|
2016
Q2 | $1.37M | Buy |
588,600
+280,900
| +91% | +$939K | 0.02% | 1039 |
|
|
2016
Q1 | $769K | Sell |
307,700
-71,600
| -19% | -$161K | 0.01% | 1374 |
|
|
2015
Q4 | $1.16M | Buy |
379,300
+110,600
| +41% | +$309K | 0.01% | 1211 |
|
|
2015
Q3 | $462K | Sell |
268,700
-13,300
| -5% | -$33.9K | 0.01% | 1841 |
|
|
2015
Q2 | $1.15M | Buy |
282,000
+61,300
| +28% | +$251K | 0.02% | 1116 |
|
|
2015
Q1 | $845K | Sell |
220,700
-140,400
| -39% | -$611K | 0.01% | 1212 |
|
|
2014
Q4 | $1.73M | Buy |
361,100
+51,000
| +16% | +$202K | 0.03% | 727 |
|
|
2014
Q3 | $1.15M | Sell |
310,100
-55,600
| -15% | -$188K | 0.02% | 1007 |
|
|
2014
Q2 | $1.33M | Sell |
365,700
-221,800
| -38% | -$814K | 0.02% | 948 |
|
|
2014
Q1 | $2.47M | Sell |
587,500
-196,700
| -25% | -$975K | 0.04% | 522 |
|
|
2013
Q4 | $3.61M | Buy |
784,200
+397,100
| +103% | +$1.77M | 0.05% | 368 |
|
|
2013
Q3 | $2.4M | Sell |
387,100
-128,700
| -25% | -$741K | 0.05% | 467 |
|
|
2013
Q2 | $2.81M | Buy |
+515,800
| New | +$1.69M | 0.07% | 283 |
|
Group One Trading's IMMU Position: Q4 2020 in Review
Group One Trading sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 50,018 shares — an estimated $4.25M sold.
Group One Trading first reported a position in IMMU in Q2 2013 and held it in 22 quarters. The position peaked at $6.51M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Group One Trading reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Group One Trading sold 50,018 Immunomedics Inc shares in Q4 2020, an estimated $4.25M.
- Group One Trading first reported a position in Immunomedics Inc in Q2 2013 and held it in 22 quarters.
- Group One Trading's Immunomedics Inc position peaked at $6.51M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Group One Trading's 13F filing for Q4 2020, filed 10 Feb 2021.